News
$Orchestra BioMed(OBIO.US$ The FDA Granted An Investigational Device Exemption To Initiate BACKBEAT Study Evaluating Orchestra Biomed's Atrioventricular Interval Modulation Therapy (BACKBEAT CNT) For Hypertensive Patients Who Are Indicated For A Dual-chamber Cardiac Pacemaker![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
